Why the study?
Does the TG/HDL-C ratio predict cardiovascular outcomes in patients with chronic kidney disease?
Population
197 patients with chronic kidney disease Stages 1 to 5, mean age 53±12 years, 51% male. Patients taking ACE…
Design
Cohort
Follow-up
mean 30 (range 9 to 35) months
Authors
Loading...
May aid CKD cardiovascular risk stratification; leaves open whether ratio modification improves outcomes.
Does the TG/HDL-C ratio predict cardiovascular outcomes in patients with chronic kidney disease?
An elevated TG/HDL-C ratio is an independent predictor of poor cardiovascular outcomes and endothelial dysfunction in patients with chronic kidney disease.
Sönmez et al. (2015) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: